Cronos Group Inc ( CRON ) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting worse-than-expected third-quarter results.

Tilray Brands Inc reported a 16.8% increase in net revenue for the third quarter ended Feb. 29, 2024, with $188.3 million in total revenue, marking a 30% year-over-year rise. The company saw significant growth in beverage-alcohol net revenue, up 165% to $54.7 million, and global cannabis net revenue increased by 33% to $63.4 million, with international cannabis growing by 44% compared to the previous year quarter.

Chairman and CEO Irwin D. Simon highlighted various accomplishments during the quarter…

Is CRON A Good Stock To Buy?

An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Cronos Group ( CRON )‘s page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.

These are known as capital allocation programs. Cronos Group ( CRON ) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.

For example, if you're looking to earn an annualized return of 110.75%, you'll need to buy a share of Lufax Holding by the Jun. 4, 2024. Once done, you can expect to receive a nominal payout of $2.37 on Jun. 8, 2024.

Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Cronos Group ( CRON ) will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.

According to data from Benzinga Pro, CRON has a 52-week high of $2.99 and a 52-week low of $1.64.

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!